Endurance Wealth Management, Inc. - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 156 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
Endurance Wealth Management, Inc. ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q2 2023$5
+25.0%
1650.0%0.00%0.0%
Q1 2023$4
+33.3%
1650.0%0.00%
Q4 2022$3
-99.8%
1650.0%0.00%
Q3 2022$2,000
-33.3%
1650.0%0.00%
Q2 2022$3,000
-25.0%
1650.0%0.00%
-100.0%
Q1 2022$4,000
-33.3%
1650.0%0.00%0.0%
Q4 2021$6,000
-25.0%
1650.0%0.00%0.0%
Q3 2021$8,000
+60.0%
1650.0%0.00%0.0%
Q2 2021$5,000
-28.6%
1650.0%0.00%0.0%
Q1 2021$7,0001650.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q3 2021
NameSharesValueWeighting ↓
DFPG INVESTMENTS, LLC 456,390$5,541,0003.62%
DAFNA Capital Management LLC 173,914$1,890,0000.65%
One68 Global Capital, LLC 19,861$216,0000.47%
Diametric Capital, LP 51,982$565,0000.41%
ARK Investment Management 1,383,756$15,041,0000.38%
EAM Investors, LLC 52,833$574,0000.13%
HIGHLINE CAPITAL MANAGEMENT, L.P. 31,404$341,0000.05%
Nikko Asset Management Americas, Inc. 280,548$3,050,0000.05%
MGO ONE SEVEN LLC 14,900$161,0000.04%
Qube Research & Technologies Ltd 67,702$736,0000.02%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders